FDA accepts Orexigen's Contrave NDA for treatment of obesity
Links shared publicly online about this topic.
- 1,124total visits
FDA accepts Orexigen's Contrave NDA for treatment of obesity
View full resource at news-medical.net
Tags: Obesity, Obesity Medication, Diet and Nutrition, Drug, FDA, Contrave, News
Most Recently Shared on June 2, 2010 at 10:46 am By:
Obesity News: FDA accepts Orexigen's Contrave NDA for treatment of obesity: Orexigen® Therapeutics, Inc., a biop... http://twurl.nl/kxptrd
Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity
news-medical.net — “Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.” View full resource at news-medical.net
Most Recently Shared on June 3, 2011 at 11:33 am By:
Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity: Orexigen Therapeutics, Inc. an... http://bit.ly/lmMFGF
FDA schedules Advisory Committee meeting to review Orexigen's Contrave NDA
news-medical.net — “Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.” View full resource at news-medical.net
Most Recently Shared on June 24, 2010 at 5:21 am By:
FDA schedules Advisory Committee meeting to review Orexigen's Contrave NDA: Orexigen® Therapeutics, Inc., a biopha... http://bit.ly/92By8E
FDA assigns PDUFA action date for Orexigen's Contrave NDA review
news-medical.net — “Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).” View full resource at news-medical.net
Most Recently Shared on June 17, 2010 at 1:49 pm By:
FDA assigns PDUFA action date for Orexigen's Contrave NDA review: Orexigen® Therapeutics, Inc., a biopharmaceutica... http://bit.ly/9b5VIG
Orexigen® Therapeutics Announces FDA Acceptance Of Contrave® New Drug Application For The Treatment Of Obesity
medicalnewstoday.com — “Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing” View full resource at medicalnewstoday.com
Most Recently Shared on June 3, 2010 at 11:56 am By:
MNT Weight Loss News Health News
Orexigen® Therapeutics Announces FDA Acceptance Of Contrave® New Drug Application For The Treatment Of Obesity http://mnt.to/3DrY
NDA submitted for Contrave for treatment of obesity - MPR
empr.com — “Orexigen announced that a New Drug Application (NDA) has been submitted to the FDA seeking approval of Contrave (naltrexone SR/bupropion SR) for the treatment of obesity.” View full resource at empr.com
Most Recently Shared on April 1, 2010 at 3:59 pm By:
MPR News: NDA submitted for Contrave for treatment of obesity: Orexigen announced that a New Drug Application (NDA... http://bit.ly/dqHz8n
Orexigen(R) Therapeutics Submits Contrave(R) New Drug Application To FDA For The Treatment Of Obesity
medicalnewstoday.com — “Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Contrave® (naltrexone S” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2010 at 11:43 am By:
MNT Weight Loss News Health News
Orexigen(R) Therapeutics Submits Contrave(R) New Drug Application To FDA For The Treatment Of Obesity http://mnt.to/3zHY #weightloss
Advertisement
